Board Certification
|
American Board of Internal Medicine (Sub: Medical Oncology)
National Board of Medical Examiners
|
Patient Rating
Patients consistently report that Dr. Gilcrease is knowledgeable, thorough, and professional, explaining diagnoses and treatment options in clear, understandable terms. Reviewers emphasize his caring, personable manner—listening closely, answering questions patiently, and helping patients feel comfortable and supported throughout care. Several comments also note confidence in his clinical judgment and praise the professionalism and friendliness of his care team.
Generated via Patient Reviews
The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers. The scale on which responses are measured is 1 to 5 with 5 being the best score.
Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.
Board Certification and Academic Information
| Academic Departments |
Internal Medicine
-Professor (Clinical) |
|---|---|
| Academic Divisions |
Oncology
|
| Board Certification |
American Board of Internal Medicine (Sub: Medical Oncology)
National Board of Medical Examiners
|
Education history
| Fellowship | Arizona Center for Integrative Medicine | Fellow |
|---|---|---|
| Fellowship | Hematology and Oncology - University of Utah | Fellow |
| Chief Resident | Scripps Mercy Hospital | Chief Medical Resident |
| Internship/Residency | Scripps Mercy Hospital | Intern/Resident |
| Professional Medical | Medicine - The University of Arizona College of Medicine | M.D. |
| Undergraduate | Spanish, Summa Cum Laude - The University of Arizona, Tucson | B.A. |
| Undergraduate | Mathematics & Computer Science, Summa Cum Laude with Honors: Honors Thesis in Mathematics Titled Young Tableaux and Semi-Invariance of Symmetric Groups - The University of Arizona, Tucson | B.S. |
Selected Publications
Journal Article
- Geranios KC, Littau MJ, Park SS, Baker TB, Gilcrease GW, Cizman Z, Smith T, Baker MS (2024). Localized hepatocellular carcinoma: Is liver-directed therapy alone as efficacious as surgical resection? Surgery, 179, 108939.
- Gumbleton M, Allan S, Conway H, Boucher K, Marvin J, Hawks J, Burnett W, Van Brocklin M, Whisenant J, Gilcrease G, Gupta S (2023). A phase I open-label study of the safety and efficacy of apatinib (rivoceranib) administered to patients with advanced malignancies to improve sensitivity to pembrolizumab in the second- or later-line setting (APPEASE). BMC Res Notes, 16(1), 16.
- Pauley K, Koptiuch C, Greenberg S, Kohlmann W, Jeter J, Colonna S, Werner T, Kinsey C, Gilcrease G, Weis J, Whisenant J, Florou V, Garrido-Laguna I (2022). Discrepancies between tumor genomic profiling and germline genetic testing. ESMO Open, 7(4), 100526.
- Martin DB, Stetson PD, Gilcrease GW, Stillman RC, Sugalski JM, Skinner J, Levy M (2021). Preferences in Oncology History Documentation Styles Among Clinical Practitioners. JCO Oncol Pract, 18(1), e1-e8.
- Martin DB, Stetson PD, Gilcrease GW, Stillman RC, Sugalski JM, Skinner J, Levy M (2021). Preferences in Oncology History Documentation Styles Among Clinical Practitioners. JCO Oncol Pract, 18(1), OP2000756.
- Florou V, Nevala-Plagemann C, Whisenant J, Maeda P, Gilcrease GW, Garrido-Laguna I (2021). Clinical Activity of Selitrectinib in a Patient With Mammary Analogue Secretory Carcinoma of the Parotid Gland With Secondary Resistance to Entrectinib. J Natl Compr Canc Netw, 19(5), 478-482.
- Wells SM, Boothe D, Ager BJ, Tao R, Gilcrease GW 3rd, Lloyd S (2020). Analysis of Nonsurgical Treatment Options for Metastatic Rectal Cancer. Clin Colorectal Cancer, 19(2), 91-99.e1.
- Nevala-Plagemann C, Moser J, Gilcrease GW, Garrido-Laguna I (2019). Survival of patients with metastatic HER2 positive gastro-oesophageal cancer treated with second-line chemotherapy plus trastuzumab or ramucirumab after progression on front-line chemotherapy plus trastuzumab. ESMO Open, 4(4), e000539.
- Weldon Gilcrease G, Stenehjem DD, Wade ML, Weis J, McGregor K, Whisenant J, Boucher KM, Thorne K, Orgain N, Garrido-Laguna I, Sharma S (2018). Phase I/II study of everolimus combined with mFOLFOX-6 and bevacizumab for first-line treatment of metastatic colorectal cancer. Invest New Drugs, 37(3), 482-489.
- Kinsey CG, Camolotto SA, Boespflug AM, Guillen KP, Foth M, Truong A, Schuman SS, Shea JE, Seipp MT, Yap JT, Burrell LD, Lum DH, Whisenant JR, Gilcrease GW 3rd, Cavalieri CC, Rehbein KM, Cutler SL, Affolter KE, Welm AL, Welm BE, Scaife CL, Snyder EL, McMahon M (2019). Protective autophagy elicited by RAF→MEK→ERK inhibition suggests a treatment strategy for RAS-driven cancers. Nat Med, 25(4), 620-627.
- Lloyd S, Baraghoshi D, Tao R, Garrido-Laguna I, Gilcrease GW 3rd, Whisenant J, Weis JR, Scaife C, Pickron TB, Huang LC, Monroe MM, Abdelaziz S, Fraser AM, Smith KR, Deshmukh V, Newman M, Rowe KG, Snyder J, Samadder NJ, Hashibe M (2019). Mental Health Disorders are More Common in Colorectal Cancer Survivors and Associated With Decreased Overall Survival. Am J Clin Oncol, 42(4), 355-362.
- Samadder NJ, Smith KR, Hanson H, Pimentel R, Wong J, Boucher K, Akerley W, Gilcrease G, Ulrich CM, Burt RW, Curtin K (2016 Mar). Familial Risk in Patients With Carcinoma of Unknown Primary. JAMA Oncol, 2(3), 340-346.
- Soldi R, Horrigan SK, Cholody MW, Padia J, Sorna V, Bearss J, Gilcrease G, Bhalla K, Verma A, Vankayalapati H, Sharma S (2015). Design, Synthesis, and Biological Evaluation of a Series of Anthracene-9,10-dione Dioxime β-Catenin Pathway Inhibitors. J Med Chem, 58(15), 5854-62.
- Ettinger DS, Handorf CR, Agulnik M, Bowles DW, Cates JM, Cristea M, Dotan E, Eaton KD, Fidias PM, Gierada D, Gilcrease GW, Godby K, Iyer R, Lenzi R, Phay J, Rashid A, Saltz L, Schwab RB, Shulman LN, Smerage JB, Stevenson MM, Varadhachary GR, Zager JS, Zhen WK, Bergman MA, Freedman-Cass DA, National Comprehensive Cancer Network (2014). Occult primary, version 3.2014. J Natl Compr Canc Netw, 12(7), 969-74.
- Garrido-Laguna I, McGregor KA, Wade M, Weis J, Gilcrease W, Burr L, Soldi R, Jakubowski L, Davidson C, Morrell G, Olpin JD, Boucher K, Jones D, Sharma S (2013). A phase I/II study of decitabine in combination with panitumumab in patients with wild-type (wt) KRAS metastatic colorectal cancer. Invest New Drugs, 31(5), 1257-64.
- Kimura BJ, Gilcrease GW 3rd, Showalter BK, Phan JN, Wolfson T (2012). Diagnostic performance of a pocket-sized ultrasound device for quick-look cardiac imaging. Am J Emerg Med, 30(1), 32-6.
- Kimura BJ, Dalugdugan R, Gilcrease GW 3rd, Phan JN, Showalter BK, Wolfson T (2011). The effect of breathing manner on inferior vena caval diameter. Eur J Echocardiogr, 12(2), 120-3.
- Gilcrease GW, Stein JB (2010). A delayed case of fatal atrioesophageal fistula following radiofrequency ablation for atrial fibrillation. J Cardiovasc Electrophysiol, 21(6), 708-11.
Case Report
- Nelson KL, Stenehjem D, Driscoll M, Gilcrease GW (2017). Fatal Statin-Induced Rhabdomyolysis by Possible Interaction with Palbociclib. Front Oncol, 7, 150.
Other
- Kinsey CG, Camolotto SA, Boespflug AM, Guillen KP, Foth M, Truong A, Schuman SS, Shea JE, Seipp MT, Yap JT, Burrell LD, Lum DH, Whisenant JR, Gilcrease GW 3rd, Cavalieri CC, Rehbein KM, Cutler SL, Affolter KE, Welm AL, Welm BE, Scaife CL, Snyder EL, McMahon M (2025). Author Correction: Protective autophagy elicited by RAF→MEK→ERK inhibition suggests a treatment strategy for RAS-driven cancers. Nat Med (31(6), p. 2069). United States.
- Kinsey CG, Camolotto SA, Boespflug AM, Guillen KP, Foth M, Truong A, Schuman SS, Shea JE, Seipp MT, Yap JT, Burrell LD, Lum DH, Whisenant JR, Gilcrease GW 3rd, Cavalieri CC, Rehbein KM, Cutler SL, Affolter KE, Welm AL, Welm BE, Scaife CL, Snyder EL, McMahon M (2019). Publisher Correction: Protective autophagy elicited by RAF→MEK→ERK inhibition suggests a treatment strategy for RAS-driven cancers. Nat Med (25(5), p. 861). United States.
Dr Gilcrease has my best interest at hand. He has done research in the cancer field and keeps my condition in mind. His recommendations have helped so far.
Doctor Gilcrease was wonderful he took his time, didn't race he explains things to me. So I understood it, he answered all my questions from me. And my family, he wasn't rushing me and his staff was wonderful. Also, he made me feel very comfortable and very upfront about things.
I was with him for a moment. I still have a test to go through. We will update later.
Very nice and easy to understand what he was telling us
Amazing and compassionate doctor.
I've said it before'.Fantastic doctor! I'm so glad I've got him on my side!!
Very good
He is always willing to listen and give caring considerate advice.
Tells me like it is
Dr. Gilcrease has always been great
Dr. Gilcrease has always left me feeling safe, secure, and well cared for. Him and his colleagues have made the healthcare process a joy, which is very surprising given the severity of my diagnosis. A great doctor in a great place full of other great people.
Good doctor. Clear straight forward.
Excellent care from a professional expert. Made a scary and apprehensive visit very comfortable.
Very helpful
Very professional and extremely knowable about my type of cancer. Gave me very good information about what to do to take on this type of cancer. Very friendly and made me feel very comfortable asking questions about treatments, no matter how dumb they were. I really liked it when he told me to get back to pumping iron and that it was ok to go to a gym again and lead a normal life. Plus, he had on wizard shoes. Outstanding cancer doctor!
Dr. Gilcrease is an incredible doctor. He's knowledgeable, personable and caring. More than anything, he continually gives me hope.
Absolutely superb doctor! Caring, knowledgeable, personable¿..really cares about his patients!!
Dr Gilcrease is very knowledgeable. He looks at you eye to eye and not at the computer while he communicates with you. He makes notes for you to remember your conversation and care plan and gives them to you! I was so impressed by his bedside manner.
Listens well, offers different treatment options and lets you do what you think is the best treatment for you even if it means no treatment as in my case.
Asks if I have questions and concerns about my treatment Great Guy along with the team
They were very informative, attentive, and answered all questions. Very friendly.
Dr Gilcrease and his team at the liver clinic have been excellent to work with. They have treated me well and with great success.
Dr. Gilcrease is outstanding. He listens to your concerns about treatments and is always there to answer any questions that you might have. He and his staff are friendly and very caring.
Exelent!!
Excellent oncologist!
Awesome
Great doctor!!
Very knowledgeable and very caring about the disease that I had I'm very happy with him great guy!!!
We had a great initial meeting with Dr. Baker. Do not hesitate to engage him as your provider.
ok I guess, do not remember.
Dr Gilcrease is very professional while being friendly and courteous. He is easy to talk to and listens attentively
Best experience ever!
His understanding of the needed treatment actually changed the planned treatment from my local Dr. From one set of drugs to another that is less brutal.
He explained everything to me and in a way where I will understand him and what he's saying to me very good
Incredibly competent and thoughtful dealing with a complex situation and treatment plan
Dr. Gilcrease is by far the best. He truly cares about his patients. He takes time to go over everything and is genuinely a friendly doctor. Thank you Dr. Gilcrease for making [NAME REMOVED]'s cancer journey so much better!
a very excellent physician
Good [TRANSLATED]
I feel well cared for by Dr Gilcrease and his staff. They are very professional and friendly.
Carrington and knowledgeable
A great physician, listens and actually engages in the conversation with you. I actually enjoy speaking with him, he is kind, professional and just an all round nice person. I trust him.
Dr Gilcrease has a fine manner and intellect along with a good memory. HeÕs on task about my situation/health and helpful with what would be the next steps. IÕve appreciated his experience and educationÉ for sure. Lucky Me.
GREAT EXPERIENCE EVERY TIME
I trust him with my medical decisions
Very kind and told me what I had to do [TRANSLATED]
Superb doctor! Can't say enough good about him!
addressed the medical issues
He is great!
Very helpful and informative. Always very compassionate and understanding.
Fantastic!
Good explanation and professional.
Dr Gilcrease is very knowledgeable and professional. He shows that he cares
Dr. Gilcrease is patient and cares deeply about your individual care needs. He is very personable and takes the time to really get to know you and develop the best treatment options.
Exceptional doctor!
Direct to the point knew what he was talking about
Very impressive with his knowledge of performing the y90 procedure!
Exceptionally good doctor. Caring, personable, knowledgeable. I can't say enough about how good Dr. Gilcrease is! I am so glad he is my oncologist.
Dr. Gilcrease is a true professional in his field and he has a passion for his craft and as a patient, you could not ask for a better Doctor to be on your side during treatment and diagnosis!
Compassionate and caring
My doctor Glynn W Gilcreas is very caring and supportive and helpful always .I am lucky to have him my doctor..he was amazing and wonderful.
Dr. Gilcrease, was very good at explaining things and answering questions. I liked his communication skills.
The doctor explained things even I could understand what he was talking about
I like him and his entire team
He was very caring and awesome doctor.
I was very impressed with the understanding and concern he showed for my condition.
Dr Gilcrease is a great oncologist. Studies your situation throughly before deciding what route to take. I am thankful for him.
I feel very comfortable and confident in Dr. Gilcrease's care.
Excellent Doctor
DR GILCREASE IS A VERY FRIENDLY AND DOWN TO EARTH PERSON. HE CARES ABOUT HIS PATIENTS, LISTENS TO THEM AND EXPLAINS TREATMENT PLANS AND PROCEDURES IN AN EASILY UNDERSTANDABLE MANNER. ALTHOUGH I HAVE AN INCURABLE DISEASE, DR GILCREASE HAS INCREASED MY CONFIDENCE IN FIGHTING IT AND MAINTAINING A GOOD QUALITY OF LIFE WHILE DOING SO.
Dr. Gilcrease is concerned with the patient's specific issues. He has an intelligent approach and he's using the most up-to-date information to resolve the cancer issue. I am very comfortable relying on his plan and my cooperation to follow his instructions to cure my cancer! He's thorough, knowledgeable, connected to the patient, has genuine concern for the patient & delivers professional care.
Very thorough in examination, questions and explanation of issues.
Great doctor